PMC:7373848 / 16105-16220 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T259","span":{"begin":34,"end":50},"obj":"Body_part"},{"id":"T260","span":{"begin":46,"end":50},"obj":"Body_part"}],"attributes":[{"id":"A259","pred":"fma_id","subj":"T259","obj":"http://purl.org/sig/ont/fma/fma66772"},{"id":"A260","pred":"fma_id","subj":"T260","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"terious and often associated with endothelial cell dysfunction. Trent et al. [31] reported dysregulated pulmonary i"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T267","span":{"begin":34,"end":50},"obj":"http://purl.obolibrary.org/obo/CL_0000115"}],"text":"terious and often associated with endothelial cell dysfunction. Trent et al. [31] reported dysregulated pulmonary i"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T544","span":{"begin":34,"end":45},"obj":"UBERON:0001986;CL:0000115"},{"id":"T545","span":{"begin":46,"end":50},"obj":"CL:0000115"},{"id":"T546","span":{"begin":91,"end":103},"obj":"GO:0065007"},{"id":"T547","span":{"begin":104,"end":113},"obj":"UBERON:0002048"}],"text":"terious and often associated with endothelial cell dysfunction. Trent et al. [31] reported dysregulated pulmonary i"}

{"project":"2_test","denotations":[{"id":"32700024-32119672-64991468","span":{"begin":78,"end":80},"obj":"32119672"}],"text":"terious and often associated with endothelial cell dysfunction. Trent et al. [31] reported dysregulated pulmonary i"}